Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productions

Fig. 2

Comparatives analyses of viability percentage and yield recovery of VNCs/mL AT between the two cohorts. Viability of SVF cells was higher in SSCF cohort compared to AP-HM cohort (p < 0.0001). Yield of VNCs/mL of AT was higher in SSCF cohort (p = 0.041). VNC, viable nucleated cell; SSCF, Swiss Stem Cell Foundation; AP-HM, Assistance Publique-Hôpitaux de Marseille; AT, adipose tissue

Back to article page